Happy New Year everyone.
Acadia has forecast a more linear growth trend over the next few quarters. I believe this will be the case for the next quarter especially having the holiday period included.
However a reminder that there will still be some larger influx of patients like the group who will be given the all clear tomorrow.
MassHealth (Boston children’s hospital) is a centre of excellence in Massachusetts who treat over 250 Rett patients.
They received notice recently that Daybue will be listed on the MassHealth Drug list from January 2, 2024
Daybue Rollout, page-117
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.54 |
Change
-0.060(0.38%) |
Mkt cap ! $1.995B | |||
| Open | High | Low | Value | Volume |
| $15.64 | $15.93 | $15.52 | $4.462M | 284.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3 | $15.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.55 | 192 | 9 |
View Market Depth
| Last trade - 14.09pm 15/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |